Playback speed
10 seconds
The MYSTIC Trial has Failed on OS in Advanced NSCLC: What Does and Doesn't This Tell Us?
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
0 views
December 4, 2018
Dr. Jack West reviews the trial design of the MYSTIC trial of durvalumab alone or ...
read more ↘ in combination with tremelimumab, what we know about results, and the implications for the current & future landscape in NSCLC.
↖ read less
read more ↘ in combination with tremelimumab, what we know about results, and the implications for the current & future landscape in NSCLC.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung